Search Result "unmethylated-celecoxib"
Exploiting Cyclooxygenase-(in)Dependent Properties of COX-2 Inhibitors for Malignant Glioma Therapy
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10 Issue: 6 Year: 2010 Page: 450-461
Author(s): Axel H. Schonthal
Selective Cyclooxygenase-2 Inhibitors for Malignant Glioma Therapy: Molecular Targets Beyond COX-2
Ebook: Advances in Anticancer Agents in Medicinal Chemistry
Volume: 1 Year: 2013
Author(s): Axel H. Schönthal
Doi: 10.2174/9781608054930113010011
Preclinical Development of Novel Anti-Glioma Drugs Targeting the Endoplasmic Reticulum Stress Response
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 2 Year: 2011 Page: 2428-2438
Author(s): Axel H. Schonthal, Thomas C. Chen, Florence M. Hofman, Stan G. Louie, Nicos A. Petasis
Novel Virally Targeted Therapies of EBV-Associated Tumors
Journal: Current Cancer Drug Targets
Volume: 8 Issue: 7 Year: 2008 Page: 581-596
Author(s): Paolo De Paoli
Mechanisms of Colon Cancer Prevention with and Beyond COX-2 Inhibition
Journal: Current Topics in Medicinal Chemistry
Volume: 5 Issue: 5 Year: 2005 Page: 505-516
Author(s): F. Rodriguez-Moranta, A. Castells
Chemoprevention of Colorectal Cancer: Progress or Pipedream?
Journal: Current Cancer Therapy Reviews
Volume: 6 Issue: 2 Year: 2010 Page: 143-156
Author(s): Rutger J. Jacobs, Liudmila L. Kodach, James C.H. Hardwick
Cancer Chemoprevention by Targeting the Epigenome
Journal: Current Drug Targets
Volume: 12 Issue: 1 Year: 2011 Page: 1925-1956
Author(s): Joseph Huang, Christoph Plass, Clarissa Gerhauser
Age-Related Inflammation: the Contribution of Different Organs, Tissues and Systems. How to Face it for Therapeutic Approaches
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 6 Year: 2010 Page: 609-618
Author(s): E. Cevenini, C. Caruso, G. Candore, M. Capri, D. Nuzzo, G. Duro, C. Rizzo, G. Colonna-Romano, D. Lio, D. Di Carlo, M. G. Palmas, M. Scurti, E. Pini, C. Franceschi, S. Vasto
Targeting the Ubiquitin-Proteasome Pathway: An Emerging Concept in Cancer Therapy
Journal: Current Topics in Medicinal Chemistry
Volume: 11 Issue: 2 Year: 2011 Page: 2888-2905
Author(s): Michael Frezza, Sara Schmitt, Q. Ping Dou
Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 9 Issue: 2 Year: 2009 Page: 151-177
Author(s): S. Rutella, G. Bonanno, R. De Cristofaro